PD-1/PD-L1 affects Graves progression through lymphocytes on the proliferation, apoptosis and inflammatory cytokine secretion of thyroid follicular epithelial cells-Reference-Cited by-同舟云学术

PD-1/PD-L1 affects Graves progression through lymphocytes on the proliferation, apoptosis and inflammatory cytokine secretion of thyroid follicular epithelial cells

Published:2020 Issue:11 Volume:45 Page:701-711
ISSN:0388-1350
Container-title:The Journal of Toxicological Sciences
language:en
Short-container-title:J. Toxicol. Sci.

Author:

Han Hui¹,Fu Xiaodan¹,Huang Jiao¹,Zhang Xianfeng¹,Yu Jianyi¹

Affiliation:

1. Department of Endocrinology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, China

Publisher

Japanese Society of Toxicology

Subject

Toxicology

Link

https://www.jstage.jst.go.jp/article/jts/45/11/45_701/_pdf

Reference33 articles.

1. Álvarez-Sierra, D., Marín-Sánchez, A., Ruiz-Blázquez, P., de Jesús Gil, C., Iglesias-Felip, C., González, Ó., Casteras, A., Costa, R.F., Nuciforo, P., Colobran, R. and Pujol-Borrell, R. (2019): Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity. J. Autoimmun., 103, 102285.

2. Ansari, M.J., Salama, A.D., Chitnis, T., Smith, R.N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S.J., Auchincloss, H. Jr. and Sayegh, M.H. (2003): The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med., 198, 63-69.

3. Baral, S., Shrestha, P.K. and Pant, V. (2017): Serum Free T₃ to Free T₄ Ratio as a Useful Indicator for Differentiating Destruction Induced Thyrotoxicosis from Graves’ Disease. J. Clin. Diagn. Res., 11, OC12-OC14.

4. Bossowski, A., Urban, M. and Stasiak-Barmuta, A. (2003): Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases. J. Pediatr. Endocrinol. Metab., 16, 63-70.

5. Chiaravalloti, A., Ursini, F., Fiorentini, A., Barbagallo, G., Martorana, A., Koch, G., Tavolozza, M. and Schillaci, O. (2017): Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT study. Sci. Rep., 7, 6220.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased plasma levels of soluble programmed death ligand 1 (sPD-L1) and fibroblast growth factor 23 (FGF-23) in patients with Graves’ ophthalmopathy in comparison to hyperthyroid patients without Graves’ ophthalmopathy;Cytokine;2023-09

2. Effects of treatment with methimazole on circulating CD4 ⁺ and CD8 ⁺ T cells positive for programed cell death protein‐1 and on subsets of CD4 ⁺ T cells in untreated hyperthyroid patients with Graves' disease;Clinical Endocrinology;2022-06-17

3. PD-L1 Inhibits T Cell-Induced Cytokines and Hyaluronan Expression via the CD40-CD40L Pathway in Orbital Fibroblasts From Patients With Thyroid Associated Ophthalmopathy;Frontiers in Immunology;2022-05-10

4. Genetics, Epigenetics, Cellular Immunology, and Gut Microbiota: Emerging Links With Graves’ Disease;Frontiers in Cell and Developmental Biology;2022-01-04

5. Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients;Endocrinology and Metabolism;2021-06-02